Maryland State Retirement & Pension System Sage Therapeutics, Inc. Transaction History

Maryland State Retirement & Pension System

  • $5.32 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021
SELL
$40.26 - $57.37 $155,725 - $221,907
-3,868 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$70.65 - $96.76 $273,274 - $374,267
3,868 New
3,868 $290,000

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
48.2M
Call Options Held
854K
Put Options Held
195K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $415M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email